SFC Capital

SFC Capital is a United Kingdom based venture capital firm founded in 2012 that focuses on early-stage investments, including pre-seed and seed rounds, in sectors such as software, technology, e-commerce, consumer products, enterprise solutions, green technology, medical technology, and hospitality. It backs UK startups through an Angel Network and seed funds, providing capital and guidance and offering access to SEIS- and EIS-qualifying investment opportunities. The firm is described as a leading seed investor in the UK.

Ricardo Berruti

Investor Services Manager

Adam Beveridge

Investment Associate

Stephen Page

CEO

Edward Prior

Head of Investor Services

Edward Stevenson

Investor

Past deals in Healthcare

CareLoop Health

Seed Round in 2025
CareLoop Health, originating from the University of Manchester, offers a digital platform that supports patients with mental health issues. It enables healthcare professionals to remotely monitor and track patient symptoms, while providing patients with personalized resources to manage their conditions. The platform uses predictive analytics to anticipate future mental health problems, helping to prevent escalation or relapse, and ultimately aims to reduce crises in mental health.

Novai

Seed Round in 2024
Novai Ltd is a British biotechnology company founded in 2019 and headquartered in Reading, United Kingdom. It commercialises DARC Technology, a patented exploratory retinal biomarker that combines a biologic agent with an artificial‑intelligence algorithm to detect cellular‑level disease activity using standard imaging equipment. DARC is approved by the FDA and MHRA for use in clinical studies of age‑related macular degeneration and glaucoma, and it can identify responders and non‑responders to therapies, enabling the creation of enriched patient cohorts and reducing the cost of ineffective treatments. The platform also offers real‑time, single‑cell visualization for eye and brain disease research, and further indications such as multiple sclerosis, Alzheimer’s disease, Parkinson’s disease, diabetes and cancer are under investigation.

Chiron Health AI

Pre Seed Round in 2024
Chiron offers a revolutionary approach to managing chronic illnesses. Based on the user's profile, it uses AI to suggest tailored self-care treatments that have the highest chance of success. It then offers a straightforward framework for evaluating the results.

LaennecAI

Pre Seed Round in 2024
LaennecAI is a clinical AI company specializing in chronic disease management solutions. It has developed a medical device, a digital stethoscope, which transforms modern smartphones into powerful diagnostic tools. The company's technology enables precise monitoring and analysis of respiratory and cardiac sounds, facilitating telemedicine, remote patient monitoring, and virtual wards. This ensures patients receive in-depth, reliable analysis and continuous care.

Reneural

Pre Seed Round in 2024
Reneural develops innovative, accessible technologies focused on improving cardiovascular disease treatment and management. Their flagship product is a wearable smart medical system designed to prevent blood clots in lower limbs, usable both clinically and at home.

Mulder

Pre Seed Round in 2024
Mulder specializes in blockchain-based traceability solutions for the medical device industry. It develops a network platform that offers real-time visibility and traceability across the entire supply chain, from raw material sourcing to patient application. This enables healthcare providers and manufacturers to verify device provenance, ensure compliance, and enhance patient safety.

ReNewVax

Pre Seed Round in 2024
ReNewVax is a biotechnology company focused on developing innovative pneumococcal vaccines aimed at preventing severe bacterial infections, including pneumonia, meningitis, and sepsis. The company's product pipeline features RVX-001, a novel protein-based vaccine designed to combat pneumococcal invasive diseases. Additionally, ReNewVax is working on RVX-002, a vaccine targeting Streptococcus pyogenes to prevent invasive neonatal diseases, and RVX-003, which addresses toxic shock syndrome caused by Streptococcus. Through its efforts, ReNewVax aims to contribute to the fight against antimicrobial resistance and enhance public health outcomes.

RS & RS Scientific

Pre Seed Round in 2024
RS & RS Scientific specializes in biotechnology, focusing on developing innovative cancer therapies. The company is committed to creating more effective treatments for various types of cancer, with a particular focus on Small Cell Lung Cancer (SCLC). They are renowned for their work on non-invasive, inhalable gene therapies.

Llusern Scientific

Seed Round in 2024
Llusern Scientific operates molecular point-of-care testing centers, focusing on urinary tract infection diagnostics. Their innovative technology rapidly detects and identifies bacteria, empowering medical professionals to make prompt decisions and enhance patient care.

4D Biomaterials

Series A in 2024
4D Medicine specializes in creating innovative solutions for the targeted and controlled regeneration of human tissue through the development of degradable, implantable medical devices. Utilizing novel photopolymer materials, the company is advancing a range of products that are currently undergoing regulatory clearance with the Food and Drug Administration. These resorbable medical devices aim to enhance patient outcomes in various applications, including musculoskeletal surgery, soft tissue repair, and drug delivery. By focusing on regulatory approval and effective medical applications, 4D Medicine seeks to provide valuable options for medical device suppliers and healthcare providers.

Medwise.ai

Seed Round in 2024
Medwise.ai operates a customizable search platform that uses natural language processing and artificial intelligence technologies to provide clinical decision support for doctors. Its real-world data offers insights to various healthcare stakeholders, enabling doctors to organize medical knowledge and enhance patient care outcomes.

Vesynta

Seed Round in 2024
Vesynta is a medical technology company that specializes in individualizing drug therapy through its innovative blood monitoring platform. The company’s technology integrates drug monitoring hardware with precision dosing software to create a universal bedside platform aimed at evidence-based clinical decision support. By utilizing robotic automation, analytical software, and machine learning, Vesynta's system determines a patient's drug exposure, empowering healthcare providers to make data-driven decisions. This approach facilitates the personalization of drug dosages, ultimately enhancing treatment outcomes while minimizing side effects for patients.

Metallo Bio

Seed Round in 2024
Metallo Bio's focus is on the development of two lead chemicals that represent a pioneering new class of antibiotics, with the goal of addressing the rising issue of antimicrobial resistance.

4D Biomaterials

Seed Round in 2024
4D Medicine specializes in creating innovative solutions for the targeted and controlled regeneration of human tissue through the development of degradable, implantable medical devices. Utilizing novel photopolymer materials, the company is advancing a range of products that are currently undergoing regulatory clearance with the Food and Drug Administration. These resorbable medical devices aim to enhance patient outcomes in various applications, including musculoskeletal surgery, soft tissue repair, and drug delivery. By focusing on regulatory approval and effective medical applications, 4D Medicine seeks to provide valuable options for medical device suppliers and healthcare providers.

Renude

Seed Round in 2024
Renude operates a personalized skincare advice platform powered by AI. It aims to make reliable, tailored consultation accessible to all users. The company's team comprises dermatologists, formulation chemists, licensed aestheticians, data scientists, and machine learning engineers dedicated to developing dermatologist-approved AI skin advisors.

Lola Cares by Leaf AI

Seed Round in 2024
Lola Cares is a therapy tool, powered by generative AI, which aims to aid memory recollection for dementia sufferers.

RegMetrics

Seed Round in 2024
RegMetrics is a developer of a medical device regulatory tool aimed at assisting health technology innovators in navigating complex medical device regulations. The company's platform leverages data-driven technologies to streamline the understanding of these regulations, making it quicker and easier for users to comply with the necessary requirements in the medical device landscape. By providing innovative solutions, RegMetrics helps facilitate the regulatory process for companies involved in the development of health technologies.

NIQS Technology

Seed Round in 2024
NIQS Technology is a spin-out from the University of Leeds specializing in innovative quantum glucose management solutions aimed at transforming diabetes care. The company has developed a patented, non-invasive glucose monitoring technology that employs a contact-based wearable device made of nano-engineered glass. This device mimics the optical properties of glucose, allowing for continuous, accurate glucose level monitoring without the need for needles or blood sampling. By providing accessible and user-friendly monitoring solutions, NIQS Technology seeks to empower individuals living with diabetes to manage their condition more effectively and improve their overall quality of life, while minimizing the risk of complications associated with traditional glucose management methods.

Corryn Biotechnologies

Seed Round in 2024
Corryn is a biotechnology company specializing in the development of advanced wound care solutions. Its flagship product, Heals device, employs contactless technology to revolutionize the treatment of chronic and complex wounds.

Fern AI

Seed Round in 2024
Fern.ai is comprehensive platform for clinical evidence review and delivers quality, speed to market, and supports compliance

Llusern Scientific

Seed Round in 2024
Llusern Scientific operates molecular point-of-care testing centers, focusing on urinary tract infection diagnostics. Their innovative technology rapidly detects and identifies bacteria, empowering medical professionals to make prompt decisions and enhance patient care.

Strolll

Seed Round in 2023
Strolll is a digital health company focused on improving mobility for people with neurological disorders. It develops a B2B digital therapeutics platform that delivers clinically validated rehabilitation software on off-the-shelf augmented reality glasses. The platform supports both in-clinic (synchronous) and at-home (asynchronous) therapy, enabling rehabilitation clinics to scale services, improve access, and reduce the cost of neurorehabilitation. By personalizing therapy, the solution aims to increase patient adherence and outcomes while streamlining administrative processes and delivering meaningful data to clinics.

Decently

Pre Seed Round in 2023
Decently is a company focused on developing advanced digital products aimed at improving lives through innovation. It operates a behavioral risk management platform designed to enhance the understanding of challenging patient behaviors. The platform includes features such as a quick observations module that monitors daily changes in behavior, mood, and patient activity. Additionally, it employs analytics to identify early signs of escalation and incorporates artificial intelligence to predict future incidents. This enables clinicians to make faster, evidence-based care decisions while also improving organizational efficiency.

Elaitra

Pre Seed Round in 2023
Elaitra develops AI-driven breast cancer diagnostic tools. Their platform includes a voice-based patient engagement system powered by Generative LLM and an AI reading tool for 3D X-rays, approved by FDA and UK regulators.

MedQ

Seed Round in 2023
MedQ is a smart platform that helps healthcare professionals complete assessments using a three-step process: Select-Send-Analyse. It is designed for clinics to transition from paper assessments to remote patient monitoring.

OSSTEC

Seed Round in 2023
OSSTEC specializes in advanced orthopedic implants, focusing on knee replacement surgeries. Its metal 3D printed implants mimic natural bone structure, reducing stress shielding, promoting bone ingrowth, and enhancing long-term implant stability for patients with osteoarthritis.

Medwise.ai

Seed Round in 2023
Medwise.ai operates a customizable search platform that uses natural language processing and artificial intelligence technologies to provide clinical decision support for doctors. Its real-world data offers insights to various healthcare stakeholders, enabling doctors to organize medical knowledge and enhance patient care outcomes.

Pinpoint Molecular

Pre Seed Round in 2023
Pinpoint Molecular develops point-of-care solutions for detecting infectious diseases. Based in London, it offers diagnostic kits and laboratory services.

Novai

Seed Round in 2023
Novai Ltd is a British biotechnology company founded in 2019 and headquartered in Reading, United Kingdom. It commercialises DARC Technology, a patented exploratory retinal biomarker that combines a biologic agent with an artificial‑intelligence algorithm to detect cellular‑level disease activity using standard imaging equipment. DARC is approved by the FDA and MHRA for use in clinical studies of age‑related macular degeneration and glaucoma, and it can identify responders and non‑responders to therapies, enabling the creation of enriched patient cohorts and reducing the cost of ineffective treatments. The platform also offers real‑time, single‑cell visualization for eye and brain disease research, and further indications such as multiple sclerosis, Alzheimer’s disease, Parkinson’s disease, diabetes and cancer are under investigation.

NIQS Technology

Seed Round in 2022
NIQS Technology is a spin-out from the University of Leeds specializing in innovative quantum glucose management solutions aimed at transforming diabetes care. The company has developed a patented, non-invasive glucose monitoring technology that employs a contact-based wearable device made of nano-engineered glass. This device mimics the optical properties of glucose, allowing for continuous, accurate glucose level monitoring without the need for needles or blood sampling. By providing accessible and user-friendly monitoring solutions, NIQS Technology seeks to empower individuals living with diabetes to manage their condition more effectively and improve their overall quality of life, while minimizing the risk of complications associated with traditional glucose management methods.

PolyMetrix

Pre Seed Round in 2022
PolyMetrix focuses on developing biometric data processing technology for the construction and healthcare sectors. It also removes demographic bias with an automated data processing pipeline and captures human facial, hand, and foot data through Ai to ensure employee safety. PolyMetrix was founded in 2021 and was headquartered in London.

Surgery Hero

Seed Round in 2022
Surgery Hero is a pioneering digital clinic specializing in prehabilitation for surgical patients. Its platform optimizes physical and mental health before surgery, reducing complications and accelerating recovery.

Hormona

Seed Round in 2022
Hormona is a pioneering femtech company dedicated to improving women's hormonal health. It offers home testing kits for accurate, pain-free hormone monitoring, supported by leading medical experts. The results seamlessly integrate with the Hormona app, empowering women to understand and manage their hormones effectively.

Renude

Seed Round in 2022
Renude operates a personalized skincare advice platform powered by AI. It aims to make reliable, tailored consultation accessible to all users. The company's team comprises dermatologists, formulation chemists, licensed aestheticians, data scientists, and machine learning engineers dedicated to developing dermatologist-approved AI skin advisors.

Strolll

Seed Round in 2022
Strolll is a digital health company focused on improving mobility for people with neurological disorders. It develops a B2B digital therapeutics platform that delivers clinically validated rehabilitation software on off-the-shelf augmented reality glasses. The platform supports both in-clinic (synchronous) and at-home (asynchronous) therapy, enabling rehabilitation clinics to scale services, improve access, and reduce the cost of neurorehabilitation. By personalizing therapy, the solution aims to increase patient adherence and outcomes while streamlining administrative processes and delivering meaningful data to clinics.

BBL Protect

Pre Seed Round in 2022
BBL Protect specializes in the development of medical devices and solutions aimed at enhancing the safe transportation of patients with infectious diseases or contaminants. The company focuses on creating patient transfer systems that prioritize infection control, ensuring the protection of patients, healthcare staff, and the surrounding environment. By delivering innovative products that emphasize safety and functionality, BBL Protect enables healthcare service providers to achieve higher standards in infection control within hospitals and emergency vehicles, thereby improving overall safety and practicality in patient transfer scenarios.

Full Stop Nutrition

Pre Seed Round in 2022
Full Stop Nutrition provides plant-based meals that control physical health. Full Stop Nutrition was founded in 2020 and was headquartered in London, United Kingdom.

Hormona

Non Equity Assistance in 2022
Hormona is a pioneering femtech company dedicated to improving women's hormonal health. It offers home testing kits for accurate, pain-free hormone monitoring, supported by leading medical experts. The results seamlessly integrate with the Hormona app, empowering women to understand and manage their hormones effectively.

Elaitra

Pre Seed Round in 2022
Elaitra develops AI-driven breast cancer diagnostic tools. Their platform includes a voice-based patient engagement system powered by Generative LLM and an AI reading tool for 3D X-rays, approved by FDA and UK regulators.

Neuroute

Pre Seed Round in 2022
Neuroute is an AI-driven platform designed to streamline clinical trial patient recruitment. It employs artificial intelligence to create targeted recruitment strategies and campaigns, connecting healthcare professionals with patients more efficiently.

Bearable

Pre Seed Round in 2022
Bearable is a health tracking application focused on wellness and mental health monitoring. The application allows users to keep track of various aspects of their health, including mood, symptoms, daily activities, sleep, medication, and exercise. It also automatically synchronizes data from wearable devices to monitor steps, heart rate, blood pressure, and weight. By consolidating this information, Bearable enables users to gain insights into how different factors affect their overall health, thereby assisting them in managing and improving their mental health conditions.

Strolll

Pre Seed Round in 2021
Strolll is a digital health company focused on improving mobility for people with neurological disorders. It develops a B2B digital therapeutics platform that delivers clinically validated rehabilitation software on off-the-shelf augmented reality glasses. The platform supports both in-clinic (synchronous) and at-home (asynchronous) therapy, enabling rehabilitation clinics to scale services, improve access, and reduce the cost of neurorehabilitation. By personalizing therapy, the solution aims to increase patient adherence and outcomes while streamlining administrative processes and delivering meaningful data to clinics.

Healome Therapeutics

Pre Seed Round in 2021
Healome Therapeutics specializes in developing treatments for ocular surface diseases. The company creates innovative 'pro-healing' microenvironments to address complex conditions, overcoming biological, chemical, and physical challenges.

Novai

Seed Round in 2021
Novai Ltd is a British biotechnology company founded in 2019 and headquartered in Reading, United Kingdom. It commercialises DARC Technology, a patented exploratory retinal biomarker that combines a biologic agent with an artificial‑intelligence algorithm to detect cellular‑level disease activity using standard imaging equipment. DARC is approved by the FDA and MHRA for use in clinical studies of age‑related macular degeneration and glaucoma, and it can identify responders and non‑responders to therapies, enabling the creation of enriched patient cohorts and reducing the cost of ineffective treatments. The platform also offers real‑time, single‑cell visualization for eye and brain disease research, and further indications such as multiple sclerosis, Alzheimer’s disease, Parkinson’s disease, diabetes and cancer are under investigation.

4D Biomaterials

Seed Round in 2021
4D Medicine specializes in creating innovative solutions for the targeted and controlled regeneration of human tissue through the development of degradable, implantable medical devices. Utilizing novel photopolymer materials, the company is advancing a range of products that are currently undergoing regulatory clearance with the Food and Drug Administration. These resorbable medical devices aim to enhance patient outcomes in various applications, including musculoskeletal surgery, soft tissue repair, and drug delivery. By focusing on regulatory approval and effective medical applications, 4D Medicine seeks to provide valuable options for medical device suppliers and healthcare providers.

Kiteline

Pre Seed Round in 2021
Kiteline Health specializes in delivering personalized content and virtual health coaching tailored for individuals dealing with chronic and long-term health conditions. The company's digital coaching services are designed to assist organizations in guiding their employees towards better health outcomes. By providing medical or psychotherapeutic treatments and setting goals to modify daily habits and lifestyles, Kiteline Health supports clients in helping their employees reduce stress and enhance sleep, diet, and exercise routines.

Help Me Stop

Pre Seed Round in 2021
Help Me Stop is a non-residential addiction treatment center focused on providing comprehensive recovery services for individuals struggling with drug and alcohol addiction. The center offers face-to-face treatment programs designed to facilitate recovery while allowing clients to maintain their daily routines. Their approach includes a variety of evidence-based methods, such as 12-step programs, cognitive behavioral therapy (CBT), psychodynamic counseling, motivational enhancement, and person-centered therapies. By emphasizing the development of self-esteem and positive coping skills, Help Me Stop aims to equip patients with the tools necessary to overcome substance abuse and improve their overall well-being.

Novai

Seed Round in 2021
Novai Ltd is a British biotechnology company founded in 2019 and headquartered in Reading, United Kingdom. It commercialises DARC Technology, a patented exploratory retinal biomarker that combines a biologic agent with an artificial‑intelligence algorithm to detect cellular‑level disease activity using standard imaging equipment. DARC is approved by the FDA and MHRA for use in clinical studies of age‑related macular degeneration and glaucoma, and it can identify responders and non‑responders to therapies, enabling the creation of enriched patient cohorts and reducing the cost of ineffective treatments. The platform also offers real‑time, single‑cell visualization for eye and brain disease research, and further indications such as multiple sclerosis, Alzheimer’s disease, Parkinson’s disease, diabetes and cancer are under investigation.

Renude

Pre Seed Round in 2021
Renude operates a personalized skincare advice platform powered by AI. It aims to make reliable, tailored consultation accessible to all users. The company's team comprises dermatologists, formulation chemists, licensed aestheticians, data scientists, and machine learning engineers dedicated to developing dermatologist-approved AI skin advisors.

Medwise.ai

Seed Round in 2021
Medwise.ai operates a customizable search platform that uses natural language processing and artificial intelligence technologies to provide clinical decision support for doctors. Its real-world data offers insights to various healthcare stakeholders, enabling doctors to organize medical knowledge and enhance patient care outcomes.

Surgery Hero

Seed Round in 2020
Surgery Hero is a pioneering digital clinic specializing in prehabilitation for surgical patients. Its platform optimizes physical and mental health before surgery, reducing complications and accelerating recovery.

4D Biomaterials

Pre Seed Round in 2020
4D Medicine specializes in creating innovative solutions for the targeted and controlled regeneration of human tissue through the development of degradable, implantable medical devices. Utilizing novel photopolymer materials, the company is advancing a range of products that are currently undergoing regulatory clearance with the Food and Drug Administration. These resorbable medical devices aim to enhance patient outcomes in various applications, including musculoskeletal surgery, soft tissue repair, and drug delivery. By focusing on regulatory approval and effective medical applications, 4D Medicine seeks to provide valuable options for medical device suppliers and healthcare providers.

Novai

Seed Round in 2020
Novai Ltd is a British biotechnology company founded in 2019 and headquartered in Reading, United Kingdom. It commercialises DARC Technology, a patented exploratory retinal biomarker that combines a biologic agent with an artificial‑intelligence algorithm to detect cellular‑level disease activity using standard imaging equipment. DARC is approved by the FDA and MHRA for use in clinical studies of age‑related macular degeneration and glaucoma, and it can identify responders and non‑responders to therapies, enabling the creation of enriched patient cohorts and reducing the cost of ineffective treatments. The platform also offers real‑time, single‑cell visualization for eye and brain disease research, and further indications such as multiple sclerosis, Alzheimer’s disease, Parkinson’s disease, diabetes and cancer are under investigation.

Transcend Packaging

Seed Round in 2020
Transcend Packaging Ltd is a UK-based company that specializes in providing sustainable packaging solutions for various industries, including food service, food and beverage, and health and beauty. Established in 2017 and located in Ystrad Mynach, Caerphilly, the company focuses on developing innovative packaging options that are environmentally friendly. Its product offerings include paper-based packaging, folded cartons, biodegradable plastics, paper straws, and digital printing services. Transcend Packaging employs advanced materials technology, such as bio-resin coated paper, to create alternatives to traditional plastic packaging, positioning itself as a leader in the sustainable packaging sector.

4D Medicine

Seed Round in 2020
Medtech

Analytic Health

Seed Round in 2020
Analytic Health provides a data-driven insights to healthcare companies that helps people to have access to medicines.

Algocyte

Seed Round in 2020
Algocyte is a UK-based company that specializes in providing comprehensive, medically-driven solutions for remote blood testing and health monitoring. The company enables healthcare professionals to remotely track and assess patients with various conditions, including cancer, anemia, and autoimmune disorders. Algocyte's innovative medical device conducts a wide range of hematological and biochemical tests, allowing for continuous health monitoring. By analyzing collected data over time, Algocyte generates detailed health profiles that offer a more accurate understanding of an individual's health status compared to traditional single-snapshot assessments.

Spintex

Seed Round in 2020
Spintex develops biomimetic technology to produce silk fibers sustainably. It uses alternative proteins and a low-energy process, aiming to reduce environmental impact while creating cost-effective, scalable fibers for sustainable fashion and advanced applications.

Safepoint

Seed Round in 2020
Safepoint provides a user-friendly app and web portal for monitoring lone workers' safety. Its intelligent features include task logging, emergency signaling, GPS location sharing, and compliance tools.

CircaGene

Pre Seed Round in 2020
CircaGene Ltd is a London-based company that specializes in bioinformatics and genetic testing services. Established in 2018, it offers a direct-to-consumer platform where individuals can order personal DNA tests while ensuring privacy through patented end-to-end encryption. The company provides actionable insights from DNA analysis to help users identify hereditary health risks, improve their lifestyle, and make informed health decisions. CircaGene's platform features user-friendly reports and connects consumers with advanced genetic research algorithms, facilitating access to comprehensive healthcare resources. By prioritizing genetic privacy and security, CircaGene aims to empower individuals to take proactive measures in managing their health and well-being.

OnCare

Seed Round in 2020
OnCare is a developer of a comprehensive care management platform tailored for care agencies. The platform simplifies and automates patient management and medical data handling, providing caregivers with tools to enhance communication and care delivery. It includes a user-friendly mobile app designed specifically for care workers, enabling them to access healthcare data, prescriptions, and related medical information in real-time. The platform also facilitates notifications and alerts regarding doctor's visits, ensuring caregivers and patients remain informed and engaged. By electronically storing medical data and maintaining digital records, OnCare empowers care agencies to improve their operational efficiency and enhance care quality, ultimately supporting positive outcomes for both caregivers and patients.

Whiterabbit.ai

Venture Round in 2020
Whiterabbit.ai develops software that uses artificial intelligence to detect cancer at the earliest stages. The company offers an AI-driven platform designed to redefine breast cancer screening and diagnosis, addressing the entire screening process from patient engagement to clinician decision support. The platform aims to improve patient compliance, enhance provider accuracy, and accelerate cancer detection in radiology by delivering targeted technology that supports medical professionals and elevates the overall quality of care.

Help Me Stop

Seed Round in 2019
Help Me Stop is a non-residential addiction treatment center focused on providing comprehensive recovery services for individuals struggling with drug and alcohol addiction. The center offers face-to-face treatment programs designed to facilitate recovery while allowing clients to maintain their daily routines. Their approach includes a variety of evidence-based methods, such as 12-step programs, cognitive behavioral therapy (CBT), psychodynamic counseling, motivational enhancement, and person-centered therapies. By emphasizing the development of self-esteem and positive coping skills, Help Me Stop aims to equip patients with the tools necessary to overcome substance abuse and improve their overall well-being.

Kineta

Venture Round in 2019
Kineta is a clinical-stage biotechnology company based in Seattle, Washington. Founded in 2007, it focuses on developing immunology-based therapies for oncology and virology. Notable products include KCP-506 for chronic pain treatment and LHF-535 for antiviral therapy against viruses like Lassa. Kineta also has drug development programs targeting RIG-I and VISTA for cancer immunotherapy.

VIVAN Therapeutics

Pre Seed Round in 2019
VIVAN Therapeutics pioneers personalized cancer therapeutics using innovative assay technology. It licenses technology from the Center for Personalized Cancer Therapeutics at Mount Sinai New York, offering a comprehensive, genomics-based drug screening service enabled by blockchain. The company's approach intelligently designs personalized treatments, combining cancer and non-cancer drugs to reduce toxicity and cost.

Help Me Stop

Seed Round in 2019
Help Me Stop is a non-residential addiction treatment center focused on providing comprehensive recovery services for individuals struggling with drug and alcohol addiction. The center offers face-to-face treatment programs designed to facilitate recovery while allowing clients to maintain their daily routines. Their approach includes a variety of evidence-based methods, such as 12-step programs, cognitive behavioral therapy (CBT), psychodynamic counseling, motivational enhancement, and person-centered therapies. By emphasizing the development of self-esteem and positive coping skills, Help Me Stop aims to equip patients with the tools necessary to overcome substance abuse and improve their overall well-being.

Protect My Pet

Seed Round in 2018
Protect My Pet Limited is a UK-based company that specializes in delivering personalized flea and worming treatments for dogs, cats, and other pets. Established in 2015 and headquartered in London, the company operates an online platform that offers subscription boxes tailored to the specific needs of each pet. These boxes are designed to ensure that treatments are delivered precisely when they are due, providing pet owners with a convenient solution for managing their pets' health. By focusing on quality medication and care, Protect My Pet aims to enhance the well-being of pets while simplifying the treatment process for their owners.

Transcend Packaging

Seed Round in 2018
Transcend Packaging Ltd is a UK-based company that specializes in providing sustainable packaging solutions for various industries, including food service, food and beverage, and health and beauty. Established in 2017 and located in Ystrad Mynach, Caerphilly, the company focuses on developing innovative packaging options that are environmentally friendly. Its product offerings include paper-based packaging, folded cartons, biodegradable plastics, paper straws, and digital printing services. Transcend Packaging employs advanced materials technology, such as bio-resin coated paper, to create alternatives to traditional plastic packaging, positioning itself as a leader in the sustainable packaging sector.

Hanx

Seed Round in 2018
HANX Limited is a London-based company that specializes in the manufacture and sale of condoms, aiming to promote sexual health and wellness. Founded in 2017 by Farah Kabir and Dr. Sarah Welsh, the company offers a variety of products, including flavored, scented, ribbed, and glow-in-the-dark condoms. All products are crafted from vegan-certified, fair trade natural latex, ensuring ethical and sustainable sourcing. With a focus on empowering women to take control of their sexual health, HANX creates gynecologist-approved condoms that are designed to be aesthetically pleasing and practical for everyday use. The products are available for purchase both online and in physical stores, reflecting the company's commitment to making sexual health discussions more accessible and reducing stigma.

OnCare

Seed Round in 2018
OnCare is a developer of a comprehensive care management platform tailored for care agencies. The platform simplifies and automates patient management and medical data handling, providing caregivers with tools to enhance communication and care delivery. It includes a user-friendly mobile app designed specifically for care workers, enabling them to access healthcare data, prescriptions, and related medical information in real-time. The platform also facilitates notifications and alerts regarding doctor's visits, ensuring caregivers and patients remain informed and engaged. By electronically storing medical data and maintaining digital records, OnCare empowers care agencies to improve their operational efficiency and enhance care quality, ultimately supporting positive outcomes for both caregivers and patients.

The Proper Food Project

Seed Round in 2018
The Proper Food Project Ltd. is a London-based company established in 2015 that specializes in the production of organic protein powders. The company offers a variety of flavors, including plain, chocolate, and vanilla. Its online platform focuses on providing environmentally conscious protein supplements, featuring organic and vegan whey protein. By facilitating online orders, The Proper Food Project aims to support consumers in leading a healthy lifestyle through the availability of nutritious food options.

Transcend Packaging

Seed Round in 2018
Transcend Packaging Ltd is a UK-based company that specializes in providing sustainable packaging solutions for various industries, including food service, food and beverage, and health and beauty. Established in 2017 and located in Ystrad Mynach, Caerphilly, the company focuses on developing innovative packaging options that are environmentally friendly. Its product offerings include paper-based packaging, folded cartons, biodegradable plastics, paper straws, and digital printing services. Transcend Packaging employs advanced materials technology, such as bio-resin coated paper, to create alternatives to traditional plastic packaging, positioning itself as a leader in the sustainable packaging sector.

Macacha

Seed Round in 2017
Macacha is a producer of natural protein shakes designed to nourish and enhance health through high-quality, plant-based ingredients. Founded by a former Head of Health and Beauty at Whole Foods UK, the company arose from the need for a protein shake that met rigorous quality standards. Macacha specializes in creating vegan protein shakes that incorporate organic whole foods, botanicals, and superfoods, while avoiding artificial ingredients and allergens such as GMO, soy, yeast, gluten, and dairy. The company emphasizes the use of complementary ingredients tailored to support various bodily systems, ensuring that each shake delivers optimal nutrition. Additionally, Macacha is committed to sustainability, utilizing eco-friendly packaging in its products.

Curamicus

Seed Round in 2017
Curamicus Ltd is a healthcare technology company based in Polegate, United Kingdom, founded in 2015. Formerly known as Hip Buddy Ltd, the company specializes in developing wearable devices that utilize sensors, artificial intelligence, and cloud technology to identify anxiety and vulnerability in elderly individuals. By creating massively scalable assistive technology, Curamicus aims to enhance the quality of life for elders and vulnerable populations, enabling them to live safer and more fulfilling lives. The focus of Curamicus is on personalized wellness solutions that effectively manage anxiety and improve overall well-being for its users.

Protect My Pet

Seed Round in 2017
Protect My Pet Limited is a UK-based company that specializes in delivering personalized flea and worming treatments for dogs, cats, and other pets. Established in 2015 and headquartered in London, the company operates an online platform that offers subscription boxes tailored to the specific needs of each pet. These boxes are designed to ensure that treatments are delivered precisely when they are due, providing pet owners with a convenient solution for managing their pets' health. By focusing on quality medication and care, Protect My Pet aims to enhance the well-being of pets while simplifying the treatment process for their owners.

Tea+

Seed Round in 2015
Tea+ is a producer of vitamin-enriched wellness teas designed to support health and wellness objectives. Each blend combines green tea with essential vitamins, herbs, and fruit flavors, ensuring that consumers receive up to 100% of their recommended daily intake of vitamins A, C, and E. The company aims to offer a convenient and functional beverage option that allows individuals to easily incorporate vital nutrients into their daily routine, thereby addressing specific health needs and goals.

Numeration Systems

Seed Round in 2015
Numeration Systems Ltd is a company based in Truro, United Kingdom, that specializes in developing granular health and wellbeing operational models and a suite of web-based tools. Founded in 2013, the company focuses on critical aspects of healthcare service management, including service repatriation, demand and capacity planning, and carbon footprint modeling. Additionally, Numeration Systems offers benchmarking and integrated care solutions aimed at redesigning healthcare services. The company also provides consultancy services to help organizations implement its operational models effectively.

UniTalk

Seed Round in 2015
UniTalk Ltd is a UK-based technology company established in 2013, headquartered in Cardiff. It specializes in developing accessible communication platforms, serving businesses, public sectors, and individuals worldwide. UniTalk's flagship product, TouchPhrase Technology, offers pre-set phrases for multi-user applications across various sectors like healthcare, education, emergency services, and retail. This technology works across diverse formats such as mobile phones, chat rooms, and text alert services. UniTalk also provides specialized communication platforms: Chabble for individuals with restricted speech and movement, Smile'n'Talk for children to practice language skills online, and MonkeyChat for safe, fun interactions among young children. The company caters to users of all ages and abilities, aiming to overcome language barriers and enhance communication accessibility.

Numeration Systems

Seed Round in 2014
Numeration Systems Ltd is a company based in Truro, United Kingdom, that specializes in developing granular health and wellbeing operational models and a suite of web-based tools. Founded in 2013, the company focuses on critical aspects of healthcare service management, including service repatriation, demand and capacity planning, and carbon footprint modeling. Additionally, Numeration Systems offers benchmarking and integrated care solutions aimed at redesigning healthcare services. The company also provides consultancy services to help organizations implement its operational models effectively.

UniTalk

Seed Round in 2014
UniTalk Ltd is a UK-based technology company established in 2013, headquartered in Cardiff. It specializes in developing accessible communication platforms, serving businesses, public sectors, and individuals worldwide. UniTalk's flagship product, TouchPhrase Technology, offers pre-set phrases for multi-user applications across various sectors like healthcare, education, emergency services, and retail. This technology works across diverse formats such as mobile phones, chat rooms, and text alert services. UniTalk also provides specialized communication platforms: Chabble for individuals with restricted speech and movement, Smile'n'Talk for children to practice language skills online, and MonkeyChat for safe, fun interactions among young children. The company caters to users of all ages and abilities, aiming to overcome language barriers and enhance communication accessibility.

FindMe Health

Seed Round in 2014
FindMe Health is an online platform designed to empower patients by providing access to reliable and comparable information on the quality and pricing of healthcare services. Targeting individuals who are seeking alternatives to NHS treatment, especially when they are ineligible or facing long waiting times, the platform allows users to compare hospital consultants based on various criteria such as procedure volume, patient feedback, hospital location, and treatment costs. This comprehensive comparison helps patients make informed decisions regarding their healthcare options. In addition to offering detailed insights on conditions, hospitals, and consultants, FindMe Health facilitates the booking of initial consultations directly through the site. By consolidating essential information in one place, it aims to simplify the often confusing landscape of self-pay healthcare and enable patients to take control of their health decisions.

Stablepharma

Seed Round in 2013
Founded in 2012, Stablepharma specializes in developing processes for vaccine stabilization. Its flagship product, Stablevax, enables precise dosage pre-loading into syringes at manufacture, eliminating wastage. The company's technology platform converts existing vaccines and diagnostics into thermostable products, addressing global cold chain challenges.

Performr.ai

Performr.ai is a Biotechnology Research firm offering monitoring and body sensors for personalised health and insights.

Avigen

Avigen is a biopharmaceutical company focused on accelerating immune cell development through innovative immunotherapy. It specializes in discovering drugs that enhance the binding strength between immune cells and their targets, enabling more precise and confident selection of potent immune candidates. This approach aims to expedite and mitigate risks in cell therapy development, ultimately benefiting healthcare professionals and patients.

Graphene Trace

Graphene Trace is a healthcare technology company that specializes in preventing pressure ulcers, a common issue among wheelchair users and hospital patients. The company's core product is a smart, pressure-sensing fabric that continuously monitors pressure distribution, alerting users and caregivers in real-time to repositioning needs. This innovative solution enables early intervention, preventing pressure ulcers, and ensuring user comfort and affordability.

SNIP Medical

SNIP Medical is a medical devices manufacturer specializing in tongue-tie correction. It produces a unique frenotomy device designed to enhance safety and reproducibility in procedures, allowing healthcare providers to treat tongue-tied infants at the point of care.

Eupnoos

Eupnoos is a health-tech company specializing in digital lung health solutions. It offers smartphone-based, automated lung function testing and data interpretation for various devices and telehealth platforms.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.